[link removed] [link removed] [link removed] [link removed] [link removed]

Email not displaying correctly? View it in your browser. ([link removed])

[link removed]
Issue 1,769: August 7, 2024
Top Stories
* Immunize​.org updates two RSV standing orders templates to protect infants: nirsevimab for infants and Abrysvo (RSV vaccine) during pregnancy (#IZX1)
* New VIS translations: Immunize​.org posts Marshallese translations of seven popular VISs (#IZX2)
* Changes coming for 2024–25 season: Vaccines.gov will discontinue tracking details of COVID-19 vaccine availability by facility. CDC plans to display locations that offer COVID-19, influenza, and RSV vaccines to public. (#IZX3)
* August is National Immunization Awareness Month; promote vaccination with CDC’s graphics and messages on your social media and websites (#IZX4)
* “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools”: updates expected when 2024–25 formulations become available (#IZX5)
* Immunize​.org’s Hepatitis B Birth Dose Honor Roll recognizes 585 institutions, including two new honorees  (#IZX6)
* “What Is the Difference between a Contraindication and a Precaution?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube. (#IZX7)
* Vaccines in the news (#IZX8)


Immunize​.org Website and Clinical Resources
* Spotlight on the website: Institutional honor rolls for vaccination excellence (#IZX9)
* Recap: Immunize​.org's website with data and maps of state immunization requirements and exemption policies for childcare and school updated for 2024 (#IZX10)
* Recap: Standing orders templates for the 2024–25 influenza season now available, along with Immunize​.org’s updated reference list of 2024–25 influenza vaccines (#IZX11)
* Recap: Standing orders template for administering pneumococcal vaccines to adults updated to include PCV21 (#IZX12)
* Recap: Turkish translation now available for Immunize​.org’s patient handout, “Immunizations for Babies: A Guide for Parents” (#IZX13)


Featured Resources
* Teaching young people about vaccines: reliable educational resources on how vaccines work (#IZX14)
* Quality improvement organizations offer an immunization microsite with billing, payment, and educational resources (#IZX15)
* Explore the www.Give2MenACWY.org website to increase coverage for meningococcal ACWY booster doses and other adolescent vaccinations (#IZX16)


Notable Publications
* “The Recombinant Shingles Vaccine Is Associated with Lower Risk of Dementia” published in Nature Medicine (#IZX17)


Global News
* “Progress toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015–April 2024” published in MMWR (#IZX18)


Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize​.org updates two RSV standing orders templates to protect infants: nirsevimab for infants and Abrysvo (RSV vaccine) during pregnancy

As you prepare to protect infants from RSV this fall through maternal vaccination (Abrysvo, Pfizer) or infant immunization (Beyfortus, Sanofi), download updated standing orders templates from Immunize​.org.
* Standing Orders for Administering Nirsevimab RSV Preventive Antibody (Beyfortus, by Sanofi) to Infants ([link removed] )
* Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) during Pregnancy ([link removed] )

Both documents were edited to clarify that if a pregnant person received RSV vaccination before the current pregnancy, the pregnant person should not receive another dose of RSV vaccine. In this situation, the infant should receive nirsevimab after delivery for RSV protection. Additional edits are as follows:

Standing Orders for Administering Nirsevimab RSV Preventive Antibody (Beyfortus, by Sanofi) to Infants ([link removed] ) was edited to remove shortage considerations, which are no longer relevant. An updated link was provided to AAP guidance on the use of palivizumab for eligible infants if nirsevimab is unavailable.

Standing Orders for Administering Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) during Pregnancy ([link removed] ) now refers users to information on vaccine components from the FDA package insert; CDC discontinued the table of vaccine excipients in the Pink Book appendix that was previously referenced.

[link removed] [link removed]

A new standing orders template for routine RSV vaccination of previously unvaccinated adults age 75 and older and adults age 60 through 74 with high risk conditions is in development and will be announced in IZ Express when it is available.

Related Links
* Immunize​.org: Vaccines A–Z: RSV (Respiratory Syncytial Virus) ([link removed]) web page
* Immunize​.org: Clinical Resources: Standing Orders Templates ([link removed]) main page
* Immunize​.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria

Back to top (#Top)

------------------------------------------------------------
New VIS translations: Immunize​.org posts Marshallese translations of seven popular VISs

Immunize​.org continues to expand its repository of VIS ([link removed]) translations, all available in print-ready PDF format. Vanderburgh County (Indiana) Health Department generously donated seven Marshallese ([link removed]) VIS translations, shown below.
* COVID-19 VIS PDF ([link removed]) (view in English ([link removed]) )
* Multi-vaccines (Your Child's First Vaccines) VIS PDF ([link removed]) (view in English ([link removed]) )
* MMR VIS PDF ([link removed]) (view in English ([link removed]) )
* MMRV VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B VIS PDF ([link removed]) (view in English ([link removed]) )
* Polio VIS PDF ([link removed]) (view in English ([link removed]) )
* Varicella VIS PDF ([link removed]) (view in English ([link removed]) )

[link removed]

Related Links
* Immunize​.org: Vaccine Information Statement ([link removed]) s main page for VISs in 47 languages ([link removed])
* Immunize​.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page

Back to top (#Top)
------------------------------------------------------------
Changes coming for 2024–25 season: Vaccines​.gov will discontinue tracking details of COVID-19 vaccine availability by facility. CDC plans to display locations that offer COVID-19, influenza, and RSV vaccines to public.

In anticipation of the fall respiratory virus season, CDC is changing the type of information it will provide on Vaccines.gov ([link removed]) and Vacunas.gov ([link removed]) (the Spanish language version). Currently, these sites offer general information about preparing for the upcoming respiratory virus season. The announced changes are described below.
* These websites will only indicate that a site (such as a pharmacy or public clinic) offers influenza, COVID-19, and/or RSV vaccine to the public. Users will need to contact the facility directly for additional information about specific brands and availability.
* The websites will no longer be limited to COVID-19 only
* More Resources: Vaccines.gov ([link removed]) and Vacunas.gov ([link removed]) offer additional resources, including a USAGov link ([link removed]) to help people connect with their local health department to determine if free vaccinations are available

[link removed]

Back to top (#Top)
------------------------------------------------------------
August is National Immunization Awareness Month; promote vaccination with CDC’s graphics and messages on your social media and websites

August is National Immunization Awareness Month ([link removed]) (NIAM). During NIAM, encourage your patients to schedule appointments to ensure they are up to date on annual exams and recommended vaccines.

[link removed]

CDC's Communication and Print Resources ([link removed]) offer advocates graphics to share on social media platforms and websites to raise awareness around the importance of staying up to date on recommended vaccines. Include #Ivax2Protect with your social media posts to amplify your messages.

Related Links
* CDC: National Immunization Awareness Month ([link removed]) web page
* CDC: Communication and Print Resources ([link removed]) main page
* CDC: Toolkit for Reaching Healthcare Professionals ([link removed]) main page
* CDC: Toolkit for Reaching Parents and Patients ([link removed]) main page

Back to top (#Top)

------------------------------------------------------------
“Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools”: updates expected when 2024–25 formulations become available

Immunize​.org reviews its Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) at least monthly, prominently indicating when it was last revised at the top of the page. The August 1 version contains no changes from the July version. Immunize​.org will update the checklist to reflect 2024–25 formulation guidance when the information is published by CDC. At present, guidance for 2023–2024 remains in effect.

Refer to the checklist for links to important information about the federal COVID-19 Bridge Access Program ([link removed]) , which provides COVID-19 vaccines at no cost to uninsured adults. This program ends in August and will not provide access to the 2024–2025 Formula COVID-19 vaccines to adults. The 2024–2025 Formula COVID-19 vaccines will continue to be available at no cost through the VFC program for eligible children through age 18 and to people with health insurance coverage for vaccination, including adults with Medicaid or Medicare.

[link removed]

All COVID-19 vaccine providers should review this checklist regularly. Download the latest documents and discard any outdated versions. The checklist is posted on Immunize​.org's Vaccines A–Z: COVID-19 ([link removed]) main page to help practices stay up to date.

Related Links
* Immunize​.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize​.org: Vaccines A–Z: COVID-19 ([link removed]) main page
* CDC: Interim Clinical Considerations ([link removed]) main page for use of COVID-19 vaccines in the United States

Back to top (#Top)

------------------------------------------------------------
Immunize​.org’s Hepatitis B Birth Dose Honor Roll recognizes 585 institutions, including two new honorees 

Immunize​.org is pleased to welcome two new institutions into its Hepatitis B Birth Dose Honor Roll ([link removed]) , for a total of 585 honorees. The birthing institutions are listed below with their reported hepatitis B birth dose coverage rates in parentheses.  
* Advocate Trinity Hospital, Chicago, IL (93%)
* Wellington Regional Medical Center, Wellington, FL (90%)

Please join us in recognizing these honorees with sustained excellence that qualify for an additional year:  
* Jefferson Einstein Montgomery Hospital, East Norriton, PA (90%) (3 years)  
* Norwalk Hospital, Norwalk, CT (91%) (3 years)
* Texas Health Huguley Fort Worth South, Burleson, TX (95%) (4 years)
* Integris Health Grove Hospital, Grove, OK (97%) (8 years)
* Oswego Hospital, Oswego, NY (95%) (8 years)

The Honor Roll includes 585 birthing institutions from 45 states, the District of Columbia, Puerto Rico, Guam, Saipan, and our U.S. military hospital in England.  
[link removed]

The Honor Roll is a key part of Immunize​.org’s initiative urging the nation’s hospitals to Give Birth to the End of Hep B ([link removed]) . Hospitals and birthing centers are recognized for attaining high coverage for hepatitis B vaccine at birth and meeting additional criteria. To learn whether your organization qualifies and to access the application form, please see Hepatitis B Birth Dose Honor Roll online ([link removed]) .

Honorees receive an 8.5" x 11" color certificate suitable for printing and framing. Their acceptance is announced through Immunize​.org’s social media channels and to IZ Express’s 54,000+ readers. 
 
Please visit the “Hepatitis B Birth Dose Honor Roll” web page that lists these institutions and celebrates their vigorous efforts to protect infants from perinatal hepatitis B transmission. 

Related Immunize​.org Resources
* Give Birth to the End of Hep B ([link removed]) main page
* Fact sheet: Do You Qualify for the Hepatitis B Birth Dose Honor Roll? If So, Apply Today. ([link removed])
* Handout on Immunize​.org’s campaign: Give Birth to the End of Hep B ([link removed])
* Hepatitis B Birth Dose Honor Roll ([link removed]) web page

Back to top (#Top)
------------------------------------------------------------
“What Is the Difference between a Contraindication and a Precaution?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube.

This week, our featured episode from the Ask the Experts Video Series is What Is the Difference between a Contraindication and a Precaution? ([link removed]) The video briefly describes conditions for an increased risk of a serious adverse reaction to a vaccine and whether or not a vaccine should be given to a patient due to risk.

The 1-minute video is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.

[link removed]

Like, follow, and share Immunize​.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])

Back to top (#Top)
------------------------------------------------------------
Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* STAT: Behind the Malaria Vaccines: A 40-Year Quest against One of Humanity’s Biggest Killers ([link removed]) (8/1/24)
* Washington Post: CDC to Offer Seasonal Flu Shots to Farmworkers amid Bird Flu Outbreak ([link removed]) (7/30/24)
* The Guardian: COVID Surges in US as Unequal Access Plagues Vaccination and Treatment Rates ([link removed]) (7/27/24)
* Gavi, The Vaccine Alliance: Scaling Up Hepatitis B Birth Dose Vaccination Will Save Lives, and Livers, Experts Say ([link removed]) (7/26/24)
* NBC: Measles Cases in the U.S. Are Already Triple Last Year’s Total, and It’s Only July ([link removed]) (7/26/24)

Back to top (#Top)
------------------------------------------------------------
Immunize​.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: Institutional honor rolls for vaccination excellence

This week’s Spotlight is on our three honor rolls. Immunize​.org recognizes healthcare organizations and colleges/universities that excel in vaccination policy and practice.

You can locate the honor rolls under the “About” menu tab by selecting the “Recognizing Excellence” menu item. Links are provided to each honor roll, along with an option to view the current honorees.

The Influenza Vaccination Honor Roll ([link removed]) recognizes healthcare organizations that require influenza vaccination for employees to protect their patients. Honorees include 1239 healthcare systems, hospitals, medical practices, pharmacies, and others.

The Hepatitis B Birth Dose Honor Roll ([link removed]) recognizes U.S. birthing institutions that achieve a hepatitis B vaccine birth dose coverage rate of 90% or greater. Honorees must also adopt birth dose policies, procedures, and protocols. Currently, there are 585 honorees.

The MenB Vaccination Honor Roll ([link removed]) recognizes institutions of higher education that adopt policies requiring or recommending MenB vaccination to protect their students and help prevent outbreaks. There are 271 honorees currently listed.

Each honor roll landing page lists the requirements for your institution to be included and displays an online application. Relevant links to government vaccination mandates, position statements from leading medical organizations, journal articles, editorials, websites, toolkits, and personal stories from those affected by these vaccine-preventable diseases are provided.

You can look for your institution among current honor roll honorees on a single page. Filter honorees by honor roll type, facility type, and by state.

Back to top (#Top)

------------------------------------------------------------
Recap: Immunize​.org's website with data and maps of state immunization requirements and exemption policies for childcare and school updated for 2024

Each year, Immunize​.org updates its state policy web pages ([link removed]) on:
* Vaccine-specific maps and data tables summarizing state immunization requirements for childcare, school, and college entry ([link removed])
* Current state vaccine exemption policies for childcare and school entry ([link removed])
* Contact links to each state’s relevant websites ([link removed]) with details about their requirements

Our data are reviewed and verified by every state immunization program each year. These resources are valuable for vaccine advocates, public health, clinicians, families, and policymakers.

Our May 2024 updates include important enhancements to help you.
* The data table structure and content was standardized
* Each data table is now downloadable as a PDF, just like the maps
* A new archive page preserves access to the 2023 data tables and maps

[link removed] [link removed]

Immunize​.org thanks our partners at state immunization programs who reviewed and updated our data. To ask questions about any of the content on our site, contact us ([link removed]) . If you have questions about a specific state’s requirements, please contact that state immunization program ([link removed]) directly.

Related Links
* Immunize​.org: State Policies: Vaccine-Specific Requirements ([link removed]) web page
* Immunize​.org: State Exemptions ([link removed]) web page
* Immunize​.org: Archive of State Childcare, School, and College Immunization Requirements and Exemption Policies ([link removed]) web page

Back to top (#Top)
------------------------------------------------------------
Recap: Standing orders templates for the 2024–25 influenza season now available, along with Immunize​.org’s updated reference list of 2024–25 influenza vaccines

Immunize​.org’s popular standing orders templates for the 2024–25 influenza season are now available on our website. These standing orders templates help you simplify providing influenza vaccine to everyone in your practice, age 6 months and older, whether you are using an injectable influenza vaccine or a live attenuated influenza vaccine.

Standing Orders for Administering Influenza Vaccine to Adults ([link removed]) and Standing Orders for Administering Influenza Vaccine to Children and Teens ([link removed]) incorporate the recent ACIP recommendation to permit the use of high dose inactivated influenza vaccine (IIV) or adjuvanted IIV for solid organ transplant recipients age 18 through 64 years and receiving immunosuppressive medication.

[link removed] [link removed]

Influenza Vaccine Products for the 2024–2025 Influenza Season ([link removed]) , our one-page reference document, is also available. For each vaccine, the manufacturer, trade name, common abbreviation, dosage form, mercury content, age range, CVX code, and product billing (CPT) code are listed.

[link removed]

Related Links
* Immunize​.org: Vaccines A–Z: Influenza ([link removed]) web page
* Immunize​.org: Clinical Resources: Standing Orders Templates ([link removed]) main page
* Immunize​.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria

Back to top (#Top)

------------------------------------------------------------
Recap: Standing orders template for administering pneumococcal vaccines to adults updated to include PCV21

Immunize​.org updated its Standing Orders for Administering Pneumococcal Vaccines to Adults ([link removed]) to include PCV21 (Capvaxive, Merck) as an acceptable option for adults recommended to receive PCV, as recommended by ACIP and CDC.

[link removed]

Related Links
* Immunize​.org: Clinical Resources: Standing Orders Templates ([link removed]) main page
* Immunize​.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
* Immunize​.org: Recommendations for Pneumococcal Vaccines Use in Children and Teens ([link removed]) (PDF)
* Immunize​.org: Vaccines A–Z: Pneumococcal ([link removed]) main page
* CDC: PneumoRecs VaxAdvisor Mobile App for Vaccine Providers ([link removed])

Back to top (#Top)

------------------------------------------------------------
Recap: Turkish translation now available for Immunize​.org’s patient handout, “Immunizations for Babies: A Guide for Parents”

Immunize​.org posted a Turkish translation ([link removed]) of the current version of its popular patient handout, Vaccinations for Babies: A Guide for Parents ([link removed]) , generously donated by Betül Polatdemir, MD, and Nur Polatdemir. This new translation joins 15 other translations of this resource to give a family-friendly, simple overview of vaccines needed in the first year of life.

[link removed]

Related Links
* Immunize​.org: Translations ([link removed]) of clinical resources and VISs
* Immunize​.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria

Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Teaching young people about vaccines: reliable educational resources on how vaccines work

Planning for the upcoming school year or looking for science projects? The resources below can help children and adolescents explore vaccines and the immune system.

For elementary school children
* The Vaccine Makers Project: Elementary School Lesson Plans ([link removed]) (3/7/18)
* CHOP: Vaccine Resources for Kids and Teens ([link removed]) includes:
+ My Vaccine Activity Book ([link removed]) (view in Spanish ([link removed]) )
+ Vax Pack Hero ([link removed]) video game
+ Various storybooks and comic books ([link removed])
* Peekaboo Kidz, The Dr Binocs Show: How Vaccines Work ([link removed]) (6:50 min.; 4/24/20)
* SciShow Kids: Why Do We Get Vaccines? ([link removed]) (3:30 min.; 11/14/17)
* TED-Ed: How Do Vaccines Work? ([link removed]) (4:35 min.; 1/12/15)

For middle school children
* The Vaccine Makers Project: Middle School Lesson Plans ([link removed])
* CDC: How Does Flu Make You Sick? ([link removed]) (57 sec.; 11/4/19)
* Science Journal for Kids and Teens: 5 Scientific Articles about Vaccination ([link removed]) for middle and high school students
* Voices for Vaccines: Thomas Jefferson to Edward Jenner ([link removed]) (1:49 min.; 7/3/18)
* UNICEF: Vaccine Education, for and with Youth ([link removed]) (4/29/24)

For high school students
* History of Vaccines: Historyofvaccines.org ([link removed])
* The Vaccine Makers Project: High School Lesson Plans ([link removed])
* Kurzgesagt—In a Nutshell: The Side Effects of Vaccines—How High Is the Risk? ([link removed]) (10:55 min.; 5/12/19)
* Science News Explores: Explainer: What Is a Vaccine? ([link removed]) (7/18/17)
* Vaxopedia ([link removed]) website
* Science Journal for Kids and Teens: 5 Scientific Articles about Vaccination ([link removed]) for middle and high school students

Back to top (#Top)

------------------------------------------------------------
Quality improvement organizations offer an immunization microsite with billing, payment, and educational resources

The IPRO Quality Innovation Network-Quality Improvement Organization (QIN-QIO), a collaboration of three organizations with decades of experience working as Medicare QIOs, posted the “What about Vaccines? Every Time!” WAVE microsite ([link removed]) to encourage providers to talk with families about vaccines. It also includes valuable resources for vaccination providers on billing and payment.

[link removed]

The microsite links directly to the WAVE Campaign Resources ([link removed]) main page for resources to support your vaccination efforts.
Back to top (#Top)

------------------------------------------------------------
Explore the www.Give2MenACWY​.org website to increase coverage for the meningococcal ACWY booster doses and other adolescent vaccinations

Immunize​.org's www.Give2MenACWY.org ([link removed]) website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines because of the pandemic, so vaccine outreach is more important than ever.

Materials on this colorful website for healthcare professionals incorporate the 2020 ACIP meningococcal vaccine recommendations ([link removed]) and coverage statistics from CDC’s National Immunization Survey–Teen (NIS–Teen). One particularly popular resource on the site is the update Algorithm for MenACWY Immunization in Adolescents 11 through 18 Years of Age ([link removed]) .

[link removed]

The website is divided into five easy-to-access sections:
* Vaccinate Teens ([link removed]) – Teen vaccination schedules and tips for improving vaccination rates
* Give 2 Doses ([link removed]) – Tools to help improve second dose coverage of MenACWY vaccine
* 16-Year-Old Visit ([link removed]) – Resources to help providers and patients remember the important vaccines recommended for 16-year-olds
* Tools for Providers ([link removed]) – Tools to explain meningococcal ACWY vaccine recommendations and improve coverage for all adolescent vaccines
* Resources ([link removed]) – Links to print materials ([link removed]) , organizations ([link removed]) involved in adolescent vaccination, personal stories ([link removed]) about the importance of vaccination, and other resources ([link removed]) of interest

The site also categorizes materials ([link removed]) according to whether they are primarily of interest to providers, to adolescents, or to parents.

Visit Give2MenACWY.org ([link removed]) and enjoy browsing (and deploying) its bountiful resources.

Related Links
* Give2MenACWY.org ([link removed]) website
* Algorithm for MenACWY Immunization in Adolescents 11–18 Years of Age ([link removed])
* MenACWY: You're Not Done If You Give Just One: Give 2 Doses to Strengthen Protection ([link removed])
* Recommending MenACWY: What to Say and How to Say It ([link removed])
* Top 10 Ways to Improve Adolescent Immunization Rates ([link removed])
* Developing an Immunization Culture in Your Office ([link removed])
* Know Your Rates: Measuring Immunization Success in Your Practice ([link removed])
* You're 16: We Recommend These Vaccines for You ([link removed])
* Dear Colleague Letter: 16-Year-Old Patients: Make Sure They Receive Their Annual Well Visit and Vaccinations ([link removed]) – signed by six medical societies
* Ask the Experts: Meningococcal ACWY ([link removed])
* CDC: ACIP Meningococcal Vaccine Recommendations ([link removed])
* CDC: Vaccination Coverage Among Adolescents Aged 13–17 Years—National Immunization Survey–Teen, United States, 2022 ([link removed])

Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“The Recombinant Shingles Vaccine Is Associated with Lower Risk of Dementia” published in Nature Medicine

In its July 25 issue, Nature Medicine published The Recombinant Shingles Vaccine Is Associated with Lower Risk of Dementia ([link removed]) . The abstract appears below.

Here we used a natural experiment opportunity created by the rapid transition from the use of live to the use of recombinant vaccines to compare the risk of dementia between vaccines. We show that the recombinant vaccine is associated with a significantly lower risk of dementia in the 6 years post-vaccination [compared to the live herpes zoster vaccine]. Specifically, receiving the recombinant vaccine is associated with a 17% increase in diagnosis-free time, translating into 164 additional days lived without a diagnosis of dementia in those subsequently affected. The recombinant shingles vaccine was also associated with lower risks of dementia compared to two other vaccines commonly used in older people: influenza and tetanus/diphtheria/pertussis vaccines. The effect was robust across multiple secondary analyses, and present in both men and women but greater in women. These findings should stimulate studies investigating the mechanisms underpinning the protection and could facilitate the
design of a large-scale randomised control trial to confirm the possible additional benefit of the recombinant shingles vaccine.

Related Link
* Washington Post: Shingles Vaccine Linked with Lower Dementia Risk, Study Shows ([link removed]) (7/30/24)

Back to top (#Top)

------------------------------------------------------------
Global News
------------------------------------------------------------
“Progress toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015–April 2024” published in MMWR

CDC published Progress toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015–April 2024 ([link removed]) on August 1 in MMWR. A portion of the summary appears below.

Hepatitis B and hepatitis C are leading causes of cirrhosis and liver cancer. In April 2015, the country of Georgia launched a hepatitis C elimination program to address its high prevalence of hepatitis C. . . .

As of April 2024, 83% of persons with chronic hepatitis C have received a diagnosis, and 86% of those diagnosed have initiated treatment. Sustained hepatitis B vaccination coverage above 90% has substantially reduced prevalence of infection in children; however, prevalence in adults remains high. . . .

Identifying persons with chronic hepatitis C who have never received a diagnosis and linking them to care, and scaling up hepatitis B screening and treatment, would accelerate progress toward hepatitis B and hepatitis C elimination by 2030.

[link removed]

Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .

Related Links
* CDC: MMWR main page ([link removed]) providing access to the MMWR family of publications
* Immunize​.org: Clinical Resources: Hepatitis B ([link removed]) main page

Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde

About IZ Express
Immunize​.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize​.org is the source of the material and provide a link to this issue ([link removed]) .

IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize​.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer ([link removed])
ISSN: 2771-8085

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA